Effects of Preactivated Autologous T Lymphocytes on CD80, CD86 and CD95 Expression by Chronic Lymphocytic Leukemia B Cells

References

• Caligaris-Cappio, F. (2000) "Biology of chronic lymphocytic leukemia", Reviews in Clinical and Experimental Hematology 4, 5–21.
   PubMedGoogle Scholar
• Keating, M.J. (1999) "Chronic lymphocytic leukemia", Seminars in Oncology 26, 107–114.
   PubMed Web of Science ®Google Scholar
• Kipps, T.J. (2000) "Chronic lymphocytic leukemia", Current Opinion in Hematology 7, 223–234.
   PubMed Web of Science ®Google Scholar
• Reed, J.C. (1998) "Molecular biology of chronic lymphocytic leukemia", Seminars in Oncology 25, 11–18.
   PubMed Web of Science ®Google Scholar
• Caligaris Cappio, F. (2000) "Cellular interactions, immunodeficiency and autoimmunity in CLL", Hematology and Cell Therapy 42, 21–25.
   PubMedGoogle Scholar
• Hamblin, T.J., Oscier, D.G. and Young, B.J. (1986) "Autoimmunity in chronic lymphocytic leukaemia", Journal of Clinical Pathology 39, 713–716.
   PubMed Web of Science ®Google Scholar
• Foa, R., Giovarelli, M., Jemma, C., Fierro, M.T., Lusso, P., Ferrando, M.L., Lauria, F. and Forni, G. (1985) "Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL2 is absorbed by the neoplastic B cell population", Blood 66, 614–619.
   PubMed Web of Science ®Google Scholar
• Scrivener, S., Kaminski, E.R., Demaine, A. and Prentice, A.G. (2001) "Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukemia: evidence of immune dysregulation", British Journal of Haematology 112, 959–964.
   PubMed Web of Science ®Google Scholar
• Totterman, T.H., Carlsson, M., Simonsson, B., Bengtsson, M. and Nilsson, K. (1989) "T-cell activation and subset patterns are altered in B-CLL and correlate with the state of the disease", Blood 2, 789–792.
   Google Scholar
• Chiorazzi, N., Fu, S.F., Montazeri, G., Kunkel, H.G., Rai, K. and Gee, T. (1979) "T cell helper defect in patients with chronic lymphocytic leukemia", Journal of Immunology 122, 1087–1090.
   PubMed Web of Science ®Google Scholar
• De Fanis, U., Dalla Mora, L., Romano, C., Sellitto, A., Tirelli, A. and Lucivero, G. (2002) "Altered constitutive and activationinduced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia", Haematologica 87, 325–327.
   PubMed Web of Science ®Google Scholar
• Tinhofer, I., Marschitz, I., Kos, M., Henn, T., Egle, A., Villunger, A. and Greil, R. (1998) "Differential sensitivity of CD4� and CD8� T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand� tumor cells in B chronic lymphocytic leukemia", Blood 91, 4273–4281.
   PubMed Web of Science ®Google Scholar
• Goolsby, C.L., Kuchnio, M., Finn, W.G. and Peterson, L. (2000) "Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(�)CD8(�) T-cell population", Cytometry 42, 188–195.
   PubMedGoogle Scholar
• Rezvany, M.R., Jeddi-Tehrani, M., Osterborg, A., Kimby, E., Wigzell, H. and Mellstedt, H. (1999) "Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset", Blood 94, 1063–1069.
   PubMed Web of Science ®Google Scholar
• Callery, R.T., Strelkauskas, A.J., Yanovich, S., Marks, S., Rosenthal, D. and Schlossman, S.F. (1980) "Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukemia", Clinical Immunology, Immunopathology 17, 451–458.
   Google Scholar
• Han, T., Bloom, M.L., Dadey, B., Bennett, G., Minowada, J., Sandberg, A.A. and Ozer, H. (1982) "Lack of autologous mixed lymphocyte reaction in patients with chronic lymphocytic leukemia: evidence for autoreactive T-cell dysfunction not correlated with phenotype, karyotype, or clinical status", Blood 60, 1075–1081.
   PubMed Web of Science ®Google Scholar
• Kay, N.E. and Kaplan, M.E. (1986) "Defective T cell responsiveness in chronic lymphocytic leukemia: analysis of activation events", Blood 67, 578–581.
   PubMed Web of Science ®Google Scholar
• Lucivero, G., Prchal, J.T., Lawton, A.R., Antonaci, S. and Bonomo, L. (1983) "Abnormal T-cell function in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: report of a case with demonstrated polyclonality of T lymphocytes", Journal of Clinical Immunology 3, 111–116.
   PubMed Web of Science ®Google Scholar
• Hill, S.J., Peters, S.H., Ayliffe, M.J., Merceica, J. and Bansal, A.S. (1999) "Reduced IL-4 and interferon-(IFN-g) expression by CD4 T cells in patients with chronic lymphocytic leukaemia", Clinical and Experimental Immunology 117, 8–11.
   PubMed Web of Science ®Google Scholar
• Cantwell, M., Hua, T., Pappas, J. and Kipps, T.J. (1997) "Acquired CD40-ligand deficiency in chronic lymphocytic leukemia", Nature Medicine 3, 984–989.
   PubMed Web of Science ®Google Scholar
• Rossi, E., Matutes, E., Morilla, R., Owusu-Ankomah, K., Heffeman, A.M. and Catovsky, D. (1996) "Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia", Leukemia 10, 494–497.
   PubMed Web of Science ®Google Scholar
• Dazzi, F., D'Andrea, E., Biasi, G., De Silvestro, G., Gaidano, G., Schena, M., Tison, T., Vianello, F., Girolami, A. and Caligaris- Cappio, F. (1995) "Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens", Clinical Immunology, Immunopathology 75, 26–32.
   PubMedGoogle Scholar
• Van Kooten, C. and Banchereau, J. (1996) "CD40-CD40 ligand: a multifunctional receptor-ligand pair", Advances in Immunology 61, 1–77.
   PubMed Web of Science ®Google Scholar
• Buhmann, R., Nolte, A., Westhaus, A., Emmerich, B. and Hallek, M. (1999) "CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogenic versus autologous T cells generates different types of effector cells", Blood 93, 1992–2002.
   PubMed Web of Science ®Google Scholar
• Krackhardt, A.M., Harig, S., Witzens, M., Broderick, R., Barrett, P. and Gribben, J.G. (2002) "T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy", Blood 100, 167–173.
   PubMed Web of Science ®Google Scholar
• Van den hove, L.E., Van Gool, S.W., Vandenberghe, P., Bakkus, M., Thielemans, K., Boogaerts, M.A. and Ceuppens, J.L. (1997) "CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules", Leukemia 11, 572–580.
   PubMed Web of Science ®Google Scholar
• Wierda, W.G., Cantwell, M.J., Woods, S.J., Rassenti, L.Z., Prussak, C.E. and Kipps, T.J. (2000) "CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia", Blood 96, 2917–2924.
   PubMed Web of Science ®Google Scholar
• Kneitz, C., Goller, M., Wilhelm, M., Mehringer, C., Wohlleben, G., Schimpl, A. and Tony, H.P. (1999) "Inhibition of T cell/B cell interaction by B-CLL cells", Leukemia 13, 98–104.
   PubMed Web of Science ®Google Scholar
• Knauf, W.U., Ehlers, B., Bisson, S. and Thiel, E. (1995) "Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia", Blood 86, 4382–4383.
   PubMed Web of Science ®Google Scholar
• Kremer, J.P., Reisbach, G., Nerl, C. and Dormer, P. (1992) "B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta", British Journal of Haematology 80, 480–487.
   PubMed Web of Science ®Google Scholar
• Lotz, M., Ranheim, E. and Kipps, T.J. (1994) "Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells", Journal of Experimental Medicine 179, 999–1004.
   PubMed Web of Science ®Google Scholar
• Sjoberg, J., Aguilar-Santelises, M., Sjogren, A.M., Pisa, E.K., Ljungdahl, A., Bjorkholm, M., Jondal, M., Mellstedt, H. and Pisa, P. (1996) "Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease", British Journal of Haematology 92, 393–400.
   PubMed Web of Science ®Google Scholar
• Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. and Pasternack, B.S. (1975) "Clinical staging of chronic lymphocytic leukemia", Blood 46, 219–234.
   PubMed Web of Science ®Google Scholar
• Greenfield, E.A., Nguyen, K.A. and Kuchroo, V.K. (1998) "CD28/B7 costimulation: a review", Critical Reviews in Immunology 18, 389–418.
   PubMed Web of Science ®Google Scholar
• Lenschow, D.J., Walunas, T.L. and Bluestone, J.A. (1996) "CD28/B7 system of T cell costimulation", Annual Review of Immunology 14, 233–258.
   PubMed Web of Science ®Google Scholar
• Krammer, P.H. (2000) "CD95's deadly mission in the immune system", Nature 407, 789–795.
   PubMed Web of Science ®Google Scholar
• Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A., Pennington, R., Watson, T.M., Reynolds, C.W., Gause, B.L., Duffey, P.L., Jaffe, E.S., Creekmore, S.P., Longo, D.L. and Kwak, L.W. (1999) "Complete molecular remissions induced by patientspecific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma", Nature Medicine 5, 1171–1177.
   PubMed Web of Science ®Google Scholar
• Harig, S., Witzens, M., Krackhardt, A.M., Trojan, A., Barrett, P., Broderick, P., Zauls, A.J. and Gribben, J.G. (2001) "Induction of cytotoxic T-cell responses against immunoglobulin V regionderived peptides modified at human leukocyte antigen-A2 binding residues", Blood 98, 2999–3005.
   PubMed Web of Science ®Google Scholar
• Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. and Levy, R. (1996) "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells", Nature Medicine 2, 52–58.
   PubMed Web of Science ®Google Scholar
• Trojan, A., Schultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W. and Gribben, J.G. (2000) "Immunoglobulin frame-work derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies", Nature Medicine 6, 667–672.
   PubMed Web of Science ®Google Scholar
• Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila- Carino, J., Osterborg, A., Wigzell, H. and Mellstedt, H. (2000) "Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukemia", British Journal of Haematology 111, 608–617.
   PubMed Web of Science ®Google Scholar
• Kamihira, S., Yamada, Y., Hirakata, Y., Tsuruda, K., Sugahara, K., Tomonaga, M., Maeda, T., Tsukasaki, K., Atogami, S. and Kobayashi, N. (1997) "Quantitative characterization and potential function of Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T leukaemias", British Journal of Haematology 99, 858–865.
   PubMed Web of Science ®Google Scholar
• Panayiotidis, P., Ganeshaguru, K., Foroni, L. and Hoddbrand, A.V. (1995) "Expression and function of the Fas antigen in B chronic lymphocytic leukemia and hairy cell leukemia", Leukemia 9, 1227–1232.
   PubMed Web of Science ®Google Scholar
• Chu, P., Deforce, D., Pedersen, I.M., Kim, Y., Kitada, S., Reed, J.C. and Kipps, T.J. (2002) "Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia", Proceedings of the National Academy of Sciences USA 99, 3854–3859.
   PubMed Web of Science ®Google Scholar
• Upshaw, J.D. Jr. and Callihan, T.R. (2002) "Spontaneous remission of B-cell chronic lymphocytic leukemia associated with T lymphocytic hyperplasia in bone marrow", Southern Medical Journal 95, 647–649.
   PubMed Web of Science ®Google Scholar